Concept information
Preferred term
Cytarabine
Type
-
mesh:Descriptor
Definition
- A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)
Broader concept
Narrower concepts
Entry terms
- 04079A1RDZ
- 147-94-4 (Cytarabine)
- 2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl-
- 33K3DB6591
- 69-74-9 (HCl)
- Arabinofuranosylcytosine
- Arabinosylcytosine
- Aracytidine
- Cytosine Arabinoside
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
04079A1RDZ
-
147-94-4 (Cytarabine)
-
2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl-
-
33K3DB6591
-
69-74-9 (HCl)
-
Cytosine arabinoside
URI
http://data.loterre.fr/ark:/67375/JVR-Z3JB8683-9
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}